Dosing strategy that mitigates cytokine release syndrome for CD3 / CD20 bispecific antibodies
MDE20260354A1Pending Publication Date: 2026-06-30REGENERON PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MDE20260354T
- Authority / Receiving Office
- MD · MD
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2019-06-13
- Filing Date
- 2019-08-30
- Publication Date
- 2026-06-30
Need to check novelty before this filing date? Find Prior Art
No text content released.